The Journal of Internal Korean Medicine (대한한방내과학회지)

The Society of Internal Korean Medicine (대한한방내과학회)
권호 표지
DOI QR코드

DOI QR Code

A Case Report of Korean Medical Intervention in a Patient with Myasthenia Gravis after Myasthenia Crisis

근무력증 위기를 겪은 중증근무력증 환자의 한의학적 중재에 관한 증례보고 1례

  • Kim, Yeseul (Dept. of Internal Korean Medicine, Dong-Guk University Ilsan Oriental Medical Hospital) ;
  • Park, Jiyoon (Dept. of Internal Korean Medicine, Dong-Guk University Ilsan Oriental Medical Hospital) ;
  • Min, Seonwoo (Dept. of Internal Korean Medicine, Dong-Guk University Ilsan Oriental Medical Hospital) ;
  • Moon, Jiseong (Dept. of Internal Korean Medicine, Dong-Guk University Ilsan Oriental Medical Hospital) ;
  • Hong, Junghwa (Dept. of Internal Korean Medicine, Dong-Guk University Ilsan Oriental Medical Hospital) ;
  • Ahn, Lib (Dept. of Internal Korean Medicine, Dong-Guk University Ilsan Oriental Medical Hospital) ;
  • Choi, Dongjun (Dept. of Internal Korean Medicine, Dong-Guk University Ilsan Oriental Medical Hospital)
  • 김예슬 (동국대학교 일산한방병원 한방내과) ;
  • 박지윤 (동국대학교 일산한방병원 한방내과) ;
  • 민선우 (동국대학교 일산한방병원 한방내과) ;
  • 문지성 (동국대학교 일산한방병원 한방내과) ;
  • 홍정화 (동국대학교 일산한방병원 한방내과) ;
  • 안립 (동국대학교 일산한방병원 한방내과) ;
  • 최동준 (동국대학교 일산한방병원 한방내과)
  • Received : 2022.04.08
  • Accepted : 2022.05.19
  • Published : 2022.05.30
Download PDF
⟨ Previous Next ⟩

Abstract

Objective: This study reports on the management of a patient with myasthenia gravis (MG) following myasthenic crisis (MC) using Korean medicine. Methods: A 77-year-old Class V MG patient was treated with acupuncture, moxibustion, and Korean herbal medicine. A manual muscle test was used to derive a Medical Research Council (MRC) score and the patient's subjective view of his dyspnea was measured to assess MG symptoms. Results: The MRC grade indicated significant deterioration after 65 days of treatment, although there was no change in the patient's subjective dyspnea assessment. But no other MG or MC complications occurred. Conclusion: This study suggests that Korean medicine could be used for the management of Class V MG patients.

Keywords

References

  1. Journal of Clinical Neurology. Textbook of neurology. Seoul: Panmun education; 2017, p. 268-74.
  2. Twork S, Wiesmeth S, Klewer J, Pohlau D, Kugler J. Quality of life and life circumstances in German myasthenia gravis patients. Health Qual Life Outcomes 2010;8:129-9. https://doi.org/10.1186/1477-7525-8-129
  3. Jayam Trouth A, Dabi A, Solieman N, Kurukumbi M, Kalyanam J. Myasthenia gravis: a review. Autoimmune Dis 2012;2012:874680. https://doi.org/10.1155/2012/874680
  4. Kozak HH, Uca AU, Teke T, Altas M, Karatas E. Myasthenia gravis with acute respiratory failure in the emergency department. Turk J Emerg Med 2016;16(2):80-2. https://doi.org/10.1016/j.tjem.2015.03.002
  5. Kim JY. Recent advances in Myasthenia Gravis. J Electrodiagn Neuromuscul Dis 2013;15(2):59-63.
  6. Park MY, Won JH, Kim SC. Acupuncture & Moxibustion Bibliographic Studies on the Wei symptom for Clinical Treatment. J Physiol Pathol Korean Med 2012;26(6):842-8.
  7. Bae YC, Park SJ. A Case Study on the Alleviation of Symptom of a Myasthenia Gravis Patient after Korean Medicine Treatment. Korean J Orient Int Med 2019;40(1):136-44. https://doi.org/10.22246/jikm.2019.40.1.136
  8. Choi SW, Song BY. A Clinical Case Study on the Effects of Bojungikgitang and Pharmacopuncture in Myasthenia Gravis Patient. J Rare Incurable Dis 2017;1(1):29-32.
  9. Hong JH, Park JW, Kim JS, Jeon WH, Cho NH, Oh SW, et al. A Case of Myasthenia Gravis with Thymoma. J Orient Chronic Dis 2000;6(1):27-32.
  10. Kim GL, Hong CH, Lee KY. Case Study on Ocular Myasthenia Gravis. J Korean Med Ophthalmol Otolaryngol Dermatol 2021;34(1):56-65. https://doi.org/10.6114/JKOOD.2021.34.1.056
  11. Ropper AH, Samuels MA, Klein J. Adams and Victor's Principles of Neurology. tenth edition. New York: In Mc Graw Hill education; 2014, p. 1472-83.
  12. Narayanaswami P, Sanders DB, Wolfe G, Benatar M, Cea G, Evoli A. International Consensus Guidance for Management of Myasthenia Gravis. Neurology 2021;96(3):114-22. https://doi.org/10.1212/WNL.0000000000011124
  13. Murthy JM, Meena AK, Chowdary GV, Narayanan JT. Myasthenia crises: Clinical features, complications and mortality. Neurol India 2005;53(1):37-40. https://doi.org/10.4103/0028-3886.15050
  14. Jung TS, Kang SS, Choi CW. Clinical Study on 1 Case of Both Lower Limbs Weakness Patient Diagnosed Wei Symptom. J Physiol Pathol Korean Med 2012;26(5):784-7.
  15. Wang L, Zhang Y, He M. Clinical predictors for the prognosis of myasthenia gravis. BMC Neurol 2017;17(1):77. https://doi.org/10.1186/s12883-017-0857-7
  16. Chen S, Xu MB, Zhou XL, Rong PQ, Jin TY, Zheng GQ. Chinese Herbal Medicine for Myasthenia Gravis: A Systematic Review and Meta-Analysis. Front Pharmacol 2018;9:969. https://doi.org/10.3389/fphar.2018.00969
  17. Mehta S. Neuromuscular disease causing acute respiratory failure. Respiratory care 2006;51(9):1016-23.
  18. Tan D, Linssen W, Liberov B. Severe Weight Loss and Dropped Head Syndrome in MuSK Myasthenia Gravis. Case Rep Clin Med 2014;03(11):587-91. https://doi.org/10.4236/crcm.2014.311127
  19. Bacci ED, Coyne KS, Poon JL, Harris L, Boscoe AN. Understanding side effects of therapy for myasthenia gravis and their impact on daily life. BMC Neurol 2019;19(1):335. https://doi.org/10.1186/s12883-019-1573-2
  20. Nacu A, Andersen JB, Lisnic V, Owe JF, Gilhus NE. Complicating autoimmune diseases in myasthenia gravis: a review. Autoimmunity 2015;48(6):362-8. https://doi.org/10.3109/08916934.2015.1030614